[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100493394":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":29,"centralContacts":50,"locations":56,"responsibleParty":75,"collaborators":77,"id":81,"slug":82,"hasResults":83,"nctId":84,"briefTitle":85,"officialTitle":86,"acronym":87,"eligibilityCriteria":88,"healthyVolunteers":83,"sex":89,"minAge":90,"maxAge":28,"enrollmentInfo":91,"targetDuration":28,"studyType":94,"phases":95,"briefSummary":97,"conditions":98,"keywords":102,"overallStatus":59,"whyStopped":28,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":111,"completionDateStruct":113,"leadSponsor":115,"locationsCount":116},{"fullName":5,"class":6},"Ciusss de L'Est de l'Île de Montréal","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Avatar Intervention","EXPERIMENTAL","The Avatar Intervention will take place over 8 consecutive weeks, with one session per week. Additional sessions (up to a maximum of 4 sessions) will be offered if needed. Each session will last approximately 60 minutes. The goal of the intervention will be to help you reduce cravings related to your cannabis use with the use of virtual reality and avatars.",[13],"Other: Avatar Intervention",{"label":15,"type":16,"description":17,"interventionNames":18},"Addiction supportive intervention","ACTIVE_COMPARATOR","The Addiction supportive intervention will take place over 8 consecutive weeks, with one session per week. Additional sessions (up to a maximum of 4 sessions) will be offered if needed. Each session will last approximately 60 minutes. The goal of the intervention will be to help you reduce cravings related to your cannabis use.",[19],"Other: Addiction supportive intervention",[21,26],{"type":6,"name":9,"description":22,"armGroupLabels":23,"otherNames":24},"8 weekly sessions of 60 minutes. Possibility of 4 additional sessions.",[9],[25],"Avatar-CUD",{"type":6,"name":15,"description":22,"armGroupLabels":27,"otherNames":28},[15],null,[30,34,36,40,43,45,47],{"name":31,"affiliation":32,"role":33},"Alexandre Dumais, MD, PhD","University of Montreal, Institut universitaire en santé mentale de Montréal","PRINCIPAL_INVESTIGATOR",{"name":35,"affiliation":32,"role":33},"Stephane Potvin, PhD",{"name":37,"affiliation":38,"role":39},"Emmanuel Stip, MD, MSc","United Arab Emirates University","STUDY_CHAIR",{"name":41,"affiliation":42,"role":39},"Amal Abdel Baki, MD, MSc","University of Montreal, Centre hospitalier de l'Université de Montréal",{"name":44,"affiliation":32,"role":39},"Robert-Paul Juster, PhD",{"name":46,"affiliation":32,"role":39},"Marie-Hélène Goulet, PhD",{"name":48,"affiliation":49,"role":39},"Luigi De Benedictis, MD","Institut universitaire en santé mentale de Montréal",[51],{"name":31,"role":52,"phone":53,"phoneExt":54,"email":55},"CONTACT","514-251-4000","3212","contact@avatar-intervention.ca",[57],{"facility":58,"status":59,"city":60,"state":61,"zip":62,"country":63,"countryCode":64,"cosmosGeoPoint":65,"geoPoint":70,"contacts":71},"Research center of the Institut universitaire en santé mentale de Montréal","RECRUITING","Montreal","Quebec","H1N 3M5","Canada","CA",{"type":66,"coordinates":67},"Point",[68,69],-73.58781,45.50884,{"lat":69,"lon":68},[72,73,74],{"name":31,"role":52,"phone":28,"phoneExt":28,"email":28},{"name":31,"role":33,"phone":28,"phoneExt":28,"email":28},{"name":35,"role":33,"phone":28,"phoneExt":28,"email":28},{"type":76,"investigatorFullName":28,"investigatorTitle":28,"investigatorAffiliation":28,"oldNameTitle":28,"oldOrganization":28},"SPONSOR",[78],{"name":79,"class":80},"Canadian Institutes of Health Research (CIHR)","OTHER_GOV","100493394","rct-comparing-avatar-intervention-to-supportive-intervention-to-reduce-cannabis-use-in-patients-with-psychotic-disorders-100493394",false,"NCT05704582","RCT Comparing Avatar Intervention to Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders","A Randomized Controlled Trial Comparing Avatar Intervention to an Addiction Supportive Intervention to Reduce Cannabis Use in Patients With Psychotic Disorders","AC2","Inclusion Criteria:\n\n* Males or females over 18 years of age who meet the DSM-5 criteria for CUD (≥4 criteria) ;\n* Patients will meet the DSM-5 criteria for schizophrenia, schizoaffective disorder, or bipolar disorder with psychotic symptoms. Diagnoses will be established with the Structured Interview for DSM-5 (SCID-5).\n\nExclusion Criteria:\n\n* Current SUD for a substance other than cannabis ;\n* Ongoing pharmacological or psychological treatment for CUD ;\n* Ongoing detoxification for cannabis withdrawal ;\n* Presence of neurological disorders ;\n* Presence of a severe and unstable physical illness ;\n* Inability to provide consent.","ALL","18 Years",{"count":92,"type":93},150,"ESTIMATED","INTERVENTIONAL",[96],"NA","The goal of this clinical trial is to conduct a single-blind randomized controlled trial to verify whether the Avatar Intervention has greater efficacy over supportive intervention to reduce cannabis use in patients with psychotic disorders.",[99,100,101],"Psychotic Disorders","Cannabis Use Disorder","Mental Health Disorder",[103,104,105,106],"cannabis","virtual reality intervention","psychotic disorders","substance use disorders","2024-02-05",{"date":109,"type":110},"2024-02-07","ACTUAL",{"date":112,"type":110},"2023-02-01",{"date":114,"type":93},"2028-01",{"name":5,"class":6},1]